Related references
Note: Only part of the references are listed.Fibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study
Daryl Ramai et al.
DIGESTIVE DISEASES AND SCIENCES (2021)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer
Takayuki Yoshino et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study
Kil-yong Lee et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2019)
The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis
Christoph Jakob Ackermann et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Prognostic Significance and Molecular Features of Signet-Ring Cell and Mucinous Components in Colorectal Carcinoma
Kentaro Inamura et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor
Niek Hugen et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Labianca et al.
ANNALS OF ONCOLOGY (2013)
Prognostic implication of mucinous histology in colorectal cancer patients treated with adjuvant FOLFOX chemotherapy
D-W Lee et al.
BRITISH JOURNAL OF CANCER (2013)
Influence of Mucinous and Signet-Ring Cell Differentiation on Epidemiological, Histological, Molecular Biological Features, and Outcome in Patients with Colorectal Carcinoma
F. Benedix et al.
ZENTRALBLATT FUR CHIRURGIE (2013)
Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base
John R. Hyngstrom et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Critical analysis of mucin and signet ring cell as prognostic factors in an Asian population of 2,764 sporadic colorectal cancers
Min-Hoe Chew et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
Primary colorectal signet-ring cell carcinoma: Clinicopathological features and postoperative survival
Tsunekazu Mizushima et al.
SURGERY TODAY (2010)
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials
Daniel Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Significance of signet-ring cells in patients with colorectal cancer
Rashmi Pande et al.
DISEASES OF THE COLON & RECTUM (2008)
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
Richard Gray et al.
LANCET (2007)
Treatment outcomes in patients with signet ring cell carcinoma of the colorectum
Won-Suk Lee et al.
AMERICAN JOURNAL OF SURGERY (2007)
A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum
HJ Kang et al.
DISEASES OF THE COLON & RECTUM (2005)
Clinical significance of signet ring cell rectal carcinoma
JS Chen et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Primary signet-ring cell carcinoma of the colorectum
B Bittorf et al.
LANGENBECKS ARCHIVES OF SURGERY (2004)